Ignite Creation Date:
2024-05-06 @ 6:23 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05641545
Status:
TERMINATED
Last Update Posted:
2022-12-07
First Post:
2022-05-02
Brief Title:
IVAC-RCC-001 A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in AdvancedMetastatic RCC Patients
Sponsor:
SLK Kliniken Heilbronn GmbH
Organization:
SLK Kliniken Heilbronn GmbH
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Renal Cell Carcinoma |
Keywords: